| Literature DB >> 35078267 |
Chrysoula Giasafaki1,2, Eleanor Grant1, Anna Hoerder-Suabedissen1, Shuichi Hayashi1,3, Sheena Lee1, Zoltán Molnár1.
Abstract
Perception is the result of interactions between the sensory periphery, thalamus, and cerebral cortex. Inputs from the retina project to the first-order dorsal lateral geniculate nucleus (dLGN), which projects to the primary visual cortex (V1). In return, the cortex innervates the thalamus. While layer 6 projections innervate all thalamic nuclei, cortical layer 5 neurons selectively project to the higher order lateral posterior nucleus (LP) and not to dLGN. It has been demonstrated that a subpopulation of layer 5 (Rbp4-Cre+) projections rewires to dLGN after monocular or binocular enucleation in young postnatal mice. However, the exact cortical regional origin of these projections was not fully determined, and it remained unclear whether these changes persisted into adulthood. In this study, we report gene expression changes observed in the dLGN after monocular enucleation at birth using microarray, qPCR at P6, and in situ hybridization at P8. We report that genes that are normally enriched in dLGN, but not LP during development are preferentially downregulated in dLGN following monocular enucleation. Comparisons with developmental gene expression patters in dLGN suggest more immature and delayed gene expression in enucleated dLGN. Combined tracing and immuno-histochemical analysis revealed that the induced layer 5 fibers that innervate enucleated dLGN originate from putative primary visual cortex and they retain increased VGluT1+ synapse formation into adulthood. Our results indicate a new form of plasticity when layer 5 driver input takes over the innervation of an originally first-order thalamic nucleus after early sensory deficit.Entities:
Keywords: Rbp4-cre; cortex; cross hierarchical cortico-thalamic plasticity; layer 5; thalamus
Mesh:
Year: 2022 PMID: 35078267 PMCID: PMC9305932 DOI: 10.1002/cne.25304
Source DB: PubMed Journal: J Comp Neurol ISSN: 0021-9967 Impact factor: 3.028
A list of the genes with differential expression in the enucleated dLGN compared to the control dLGN at P6 using Limma with a fold change cut off value of > 1.3 or < 0.77. Moderated p value is based on the moderated t‐statistic generated by Limma analysis. Downregulated genes are shaded blue. Upregulated genes are shaded red
| Gene symbol | Gene name | Fold‐change | Moderated |
|---|---|---|---|
| RIKEN cDNA E530001K10 gene | 0.30 | .000000003 | |
| Hmcn1 | hemicentin 1 | 0.50 | .000000098 |
| Shc3 | src homology 2 domain‐containing transforming protein C3 | 0.57 | .000000034 |
| Kcnk9 | potassium channel, subfamily K, member 9 | 0.57 | .000000039 |
| Dgkk | diacylglycerol kinase kappa | 0.61 | .000008096 |
| Hcrtr2 | hypocretin (orexin) receptor 2 | 0.66 | .000000509 |
| Fam19a4 | Family with sequence similarity 19, member A4 | 0.66 | .000011353 |
| Osbp13 | Oxysterol binding protein‐like 3 | 0.66 | .000000539 |
| Dusp4 | Dual specificity phosphatase 4 | 0.67 | .000014830 |
| Gjd2 | Gap junction protein, delta 2 | 0.68 | .000000046 |
| Vsnl1 | Visinin‐like 1 | 0.68 | .000006828 |
| Tacstd2 | Tumor‐associated calcium signal transducer 2 | 0.7 | .000015436 |
| Myot | Myotilin | 0.7 | .000000174 |
| Sncg | Synuclein, gamma | 0.7 | .000003186 |
| Spred2 | Sprouty‐related, EVH1 domain containing 2 | 0.7 | .000000123 |
| 6530302D11Rik | RIKEN cDNA 6530402D11 gene | 0.7 | .000059895 |
| Moxd1 | Monooxygenase, DBH‐like 1 | 0.7 | .000019658 |
| Kcnn3 | Potassium intermediate/small conductance calcium‐activated channel, subfamily N, member 3 | 0.71 | .000027230 |
| Shisa6 | Shisa homologue 6 (Xenopus laevis) | 0.74 | .000001553 |
| Chrm2 | Cholinergic receptor, muscarinic 2, cardiac | 0.74 | .000107831 |
| Adra1d | Adrenergic receptor, alpha 1d | 0.75 | .000006886 |
| Fos | FBJ osteosarcoma oncogene | 0.75 | .000010900 |
| Frem3 | Fras1 related extracellular matrix protein 3 | 0.75 | .000003221 |
| Ptgr1 | Prostaglandin reductase 1 | 0.75 | .000275161 |
| Hmgn5 | High‐mobility group nucleosome binding domain 5 | 0.75 | .000043902 |
| Gfra1 | Glial cell line derived neurotrophic factor family receptor alpha 1 | 0.76 | .000025735 |
| Dgkg | Diacylglycerol kinase, gamma | 0.76 | .000027844 |
| Igf1 | Insulin‐like growth factor 1 | 0.76 | .000001483 |
| Pdlim5 | PDZ and LIM domain 5 | 0.76 | .000108262 |
| Col6a5 | Collagen, type VI, domain 5 | 0.76 | .000095315 |
| Synm | Synemin, intermediate filament protein | 0.76 | .000130799 |
| Chst2 | Carbohydrate sulfotransferase 2 | 0.77 | .000001235 |
| Calb2 | Calbindin 2 | 0.77 | .000041262 |
| Adamts3 | A disintegrin‐like and metallopeptidase (reprolysin type) with thrombospondin type 1 motif, 3 | 0.77 | .000026403 |
| Timp4 | Tissue inhibitor of metalloproteinase 4 | 0.77 | .000058683 |
| Egr2 | Early growth response 2 | 0.78 | .000181961 |
| Mxd4 | Max dimerization protein 4 | 1.3 | .000002559 |
| Siah3 | Seven in absentia homologue 3 (Drosophila) | 1.3 | .000057871 |
| Rmnd5a | Required for mitotic nuclear division 5 homologue A (S. cerevisiae) | 1.32 | .000062927 |
| Rnf114 | Ring finger protein 114 | 1.32 | .000214415 |
| Krtap31‐2 | Keratin associated protein 31–2 | 1.32 | .000095722 |
| Gpr17 | G protein coupled receptor 17 | 1.32 | .000322515 |
| Otx2 | Orthodenticle homologue 2 (Drosophila) | 1.34 | .000045170 |
| Ucp2 | Uncoupling protein 2 (mitochondrial, proton carrier) | 1.34 | .000467815 |
| Plp1 | Proteolipid protein (myelin) 1 | 1.35 | .000000428 |
| Snord116 | Small nucleolar RNA, C/D box 116 | 1.35 | .000004984 |
| Mir382 | microRNA 382 | 1.4 | .000372021 |
| CD24a | CD24a antigen | 1.4 | .000069054 |
| Cbln2 | Cerebellin 2 precursor protein | 1.41 | .000079102 |
| Taf1d | TATA box binding protein (Tbp)‐associated factor, RNA polymerase I, D | 1.43 | .000002259 |
| Igf2 | Insulin‐like growth factor 2 | 1.45 | .000002819 |
| Txnip | Thiredoxin interacting protein | 1.52 | .000373164 |
| Rny3 | RNA, Y3 small cytoplasmic (associated with Ro protein) | 1.53 | .000183736 |
FIGURE 1Fold change of gene expression in enucleated dLGN (contralateral to the enucleation) compared to control dLGN (ipsilateral to the enucleation) for the qPCR validation of the microarray results. (a) 22 genes were chosen from the microarray list of differentially expressed genes to perform real time, quantitative PCR (RT qPCR). Relative expression of all the genes, as assessed by qPCR, was in the same direction as relative expression assessed by the microarray. (b) The significance of relative gene expression level of 22 genes in the enucleated dLGN compared to the control dLGN, as assessed by qPCR. All but one of these 22 genes (Adamts3) were significantly differently expressed in the enucleated dLGN comprared to the control dLGN. Values shown are mean and standard error. One tailed, paired t‐test was performed to assess statistical significance. * = significant at p = .05, ** = significant at p = .005, *** = significant at p < .0005. dLGN, dorsal lateral geniculate nucleus
FIGURE 2Delay in dLGN transcriptome maturation after P0 enucleation. The schematic left panel indicates the comparisons of our dLGN gene expression data of enucleated and control dLGN from monocularly enucleated mice at P6 with the normal dLGN gene expression at P0 and P10 from Frangeul et al. (2016). Right panel: Graph showing genes which were differentially expressed after enucleation and over development. The fold change of genes differentially expressed in the enucleated dLGN compared to the control dLGN was plotted against their fold change value in the P10 dLGN compared to the P0 dLGN. Most genes are downregulated in the enucleated dLGN. Most of these downregulated genes are upregulated in the dLGN over development. Of the few genes which were upregulated after enucleation, eight were upregulated and six were down regulated over development. The transcriptome of P0 enucleated dLGN at P6 is more similar to the early dLGN gene expression (a) than to the age‐matched controls (b) suggesting delayed transcriptomic maturation. The normal developmental data has been compared to the gene expression changes observed in the enucleated dLGN. Left panel depicts the fold change after enucleation plotted against fold change over development
List of the genes with differential expression in the enucleated dLGN compared to the control dLGN (left) and the P10 dLGN compared to the P0 dLGN (right). List generated using ANOVA/t‐test intercept method using a fold change cut off value of > 1.3 or ← 1.3. Downregulated genes are shaded blue. Upregulated genes are shaded red. Genes not identified in Limma analysis denoted*
| Gene symbol | Gene name | Fold‐change | Fold‐change over development P0‐P10 |
|---|---|---|---|
| Shc3 | src homology 2 domain‐containing transforming protein C3 | −1.8219 | 3.4082 |
| Hcrtr2 | hypocretin (orexin) receptor 2 | −1.62088 | 1.2800 |
| Osbpl3 | oxysterol binding protein‐like 3 | −1.52345 | −1.1790 |
| Moxd1 | monooxygenase, DBH‐like 1 | −1.51864 | 3.1421 |
| Myot | myotilin | −1.51491 | 9.7488 |
| Tacstd2 | tumor‐associated calcium signal transducer 2 | −1.49733 | 1.5370 |
| Spred2 | sprouty‐related, EVH1 domain containing 2 | −1.48255 | 1.2718 |
| Gjd2 | gap junction protein, delta 2 | −1.47835 | 1.3583 |
| Fam19a4 | family with sequence similarity 19, member A4 | −1.4642 | 3.9706 |
| Vsnl1 | visinin‐like 1 | −1.46326 | 10.5566 |
| Kcnn3 | potassium intermediate/small conductance calcium‐activated channel, subfamily N, member 3 | −1.45767 | −1.0089 |
| Ecm2 | extracellular matrix protein 2 | −1.42854 | 1.0527 |
| Ptgr1 | prostaglandin reductase 1 | −1.41455 | 2.3981 |
| Sncg | synuclein, gamma | −1.40086 | 4.3147 |
| Synm | synemin, intermediate filament protein | −1.39202 | 9.4875 |
| Dgkg | diacylglycerol kinase, gamma | −1.38908 | 12.1429 |
| Pdlim5 | PDZ and LIM domain 5 | −1.37741 | 5.3178 |
| Egr2 | early growth response 2 | −1.35228 | −1.1871 |
| 2610318N02Rik * | −1.34751 | −2.1116 | |
| Shisa6 | shisa homologue 6 (Xenopus laevis) | −1.34632 | 3.5749 |
| Fos | FBJ osteosarcoma oncogene | −1.34455 | 1.6558 |
| Hmgb2 | high mobility group box 2 * | −1.34431 | −1.6807 |
| Calb2 | calbindin 2 | −1.34087 | 4.7060 |
| Lce1c | late cornified envelope 1C * | −1.33336 | 1.1469 |
| Igf1 | insulin‐like growth factor 1 | −1.33168 | 7.3543 |
| Pvt1 | plasmacytoma variant translocation 1 * | −1.3302 | 3.7026 |
| Timp4 | tissue inhibitor of metalloproteinase 4 | −1.31561 | 5.5110 |
| Hmgn5 | high mobility group box 5 | −1.30998 | 3.8549 |
| Chst2 | carbohydrate sulfotransferase 2 | −1.3083 | 1.4138 |
| Gfra1 | glial cell line derived neurotrophic factor family receptor alpha 1 | −1.30756 | 1.8884 |
| Ucp2 | uncoupling protein 2 | 1.31643 | 1.2418 |
| Tac1 | tachykinin 1 * | 1.3246 | 1.9175 |
| Rnf114 | ring finger protein 114 | 1.32678 | 1.0594 |
| Gpr17 | G protein‐coupled receptor 17 | 1.34438 | 8.1938 |
| Hist1h4c | histone cluster 1 h4c * | 1.36685 | −3.9876 |
| Rmnd5a | required for meiotic nuclear division 5 homologue A | 1.36687 | 1.3232 |
| Otx2 | orthodenticle homologue 2 (Drosophila) | 1.37712 | 2.5278 |
| Cd24a | CD24a antigen | 1.41627 | −8.4301 |
| Taf1d | TATA box binding protein (Tbp)‐associated factor, RNA polymerase I, D | 1.4188 | −1.2019 |
| Cbln2 | cerebellin 2 precursor protein | 1.44633 | −2.8478 |
| Txnip | thioredoxin interacting protein | 1.55786 | −2.3892 |
| Ptgds | prostaglandin synthase * | 2.03973 | 2.2592 |
FIGURE 3Comparisons of gene expression patterns after neonatal monocular enucleation between the control (ipsilateral to the enucleation) and enucleated (contralateral to the enucleation) sides of the same brain for selected genes revealed with in situ hybridization at P8. Low power permanent (upper panels) and higher power permanent and fluorescent (lower panels) in situ hybridization images of selected gene expression patterns in dLGN and vLGN at P8 ipsilateral to (control, left columns) and contralateral to (enucleated, right columns) the neonatal enucleation. We show two selected gene expression patterns: Otx2 (a–c1) and Cerebellin 2 precursor protein Cbln2 (d–e2). Cell density (c) and signal intensity (c1) of Otx2 were significantly increased in the enucleated dLGN compared to the control. In addition to the changes of dLGN gene expression after enucleation, we observed increased expression of Otx2 in the vLGN of the enucleated side. Results for quantifications for (c), (c1), (f), (i), and (l) based on n = 3 animals, at least three medial sections of control and enucleated dLGN per animal. Values shown are mean and standard error. ** = significant at p < .01, **** = significant at p < .0001. dLGN, dorsal lateral geniculate nucleus; vLGN, ventral lateral geniculate nucleus; a.u., arbitrary unit. Scale bars: 200 μm
FIGURE 4Comparisons of gene expression patterns after neonatal monocular enucleation between the control (ipsilateral to the enucleation) and enucleated (contralateral to the enucleation) sides of the same brain for selected genes revealed with in situ hybridization at P8. Low power permanent (upper panels) and higher power permanent and fluorescent (lower panels) in situ hybridization images of selected gene expression patterns in dLGN, vLGN, and LP at P8 ipsilateral to (control, left columns) and contralateral to (enucleated, right columns) the neonatal enucleation. We show two selected gene expression patterns: Calbindin 2 (Calb2) (a–b2) and Efna5 (c–d2). Calb2 expression appeared to be downregulated after enucleation (b1‐b2). In addition to the changes of dLGN gene expression after enucleation, we observed additional modifications in other thalamic nuclei. We detected increased expression of Calb2 in the vLGN of the enucleated side, as well as increased Efna5 expression in the enucleated LP. Abbreviations: dLGN, dorsal lateral geniculate nucleus; vLGN, ventral lateral geniculate nucleus; LP, lateral posterior nucleus. Scale bars: 200μm
FIGURE 5Layer 5 corticothalamic axons originate from V1 and not S1 in the contralateral dLGN following monocular enucleation at P0 in adult Rbp4::tdTom mice. Coronal sections of cortical S1 and V1 injections with AAV GFP Cre‐independent virus in adult mice. (a‐a1) In control conditions (no enucleation), corticothalamic projections from S1 innervate the somatosensory thalamic nuclei, VPM and Po (images adapted from Allen Institute for Brain Science). (b‐b1) In mice monocularly enucleated at P0, corticothalamic projections follow the same pattern as in the control non enucleated condition, innervating only the VPM and Po and completely bypassing dLGN. (c, d) High magnification images showing the colocalization of GFP+ tdTom+ cells at the site of injection in V1. Note that the majority of the GFP+ cells are situated in layer 5 colocalizing with layer 5 tdTom+ cells, with only low GFP signal detected outside of layer 5. (c1, e‐e1) In control mice, corticothalamic axons from V1 project to the visual thalamic nuclei, dLGN and LP. (d1, f‐f1) In monocularly enucleated mice, axons from V1 innervate contralateral (enucleated) dLGN and LP, showing rewiring inside dLGN compared to the control mice, with axons crossing through the lower latero‐medial part and the dorsal part of the structure. (e1, f1) High magnification images of dLGN with tdTom+ GFP+ axonal terminals (white arrows) in control and enucleated dLGN, respectively. (b1), (c1), and (d1) images have faint green signals in hippocampal mossy fibers and in dentate gyrus because of slight bleed‐through of the very strong tdTomato signal. Abbreviations: AAV, adeno‐associated virus; GFP, green fluorescent protein; S1, primary somatosensory cortex; V1, primary visual cortex; VPM, ventral‐posteromedial nucleus; Po, posterior thalamic nucleus; dLGN, dorsal lateral geniculate nucleus; LP, lateral posterior nucleus; V, layer 5; VI, layer 6. Scale bars: (a‐a1) were scaled as (b–f1), 200 μm (b‐c1, e, f), 10 μm (e1, f1)
FIGURE 6Changes in dLGN size and layer 5 axon innervation and synaptic formation in the dLGN of control (non‐enucleated mice) and monocularly enucleated Rbp4‐Cre::tdTomato adult mice contralateral to the enucleation. (a, b) The area of dLGN in mm2 in coronal sections in control and enucleated adult animals. After enucleation, the contralateral dLGN with reduced retinal input appears significantly decreased in size (c) in comparison with the control conditions without anucleation (area of dLGN and LP demarcated with the dotted white lines). (d) In control dLGN, layer 5 axons innervate and pass through the medial part of dLGN with very few axons crossing through the dorsal part (white bracket). (e) Following enucleation at birth, axons exhibit rearrangement inside dLGN, with projections sprouting through the dorsal part of dLGN forming a bundle of fibers (white bracket), that is significantly thicker in the enucleated dLGN (f) in comparison with the control (e). (g–h) High magnification images of the area demarcated by the white boxes in (d) and (e) respectively, demonstrating immunostaining against the presynaptic marker VGluT1, with density of synaptic boutons significantly increased in the enucleated dLGN compared to the control (i). Results for quantifications for (c) and (f) based on n = 9 independent samples and for (i) based on n = 3 animals, at least three medial sections per animal. Values shown are mean and standard error. ** = significant at p < .01, **** = significant at p < .0001. dLGN, dorsal lateral geniculate nucleus; LP, lateral posterior nucleus; VGluT1, vesicular glutamate transporter 1. Scale bars: 300 μm (a–b), 200 μm (d–e), 10 μm (g–h)